Anthony Durkacz detailed the status of multiple sclerosis drug Lucid-MS and the unbuzzd IPO process.
Live Poll
Do you believe pharmaceutical companies are successfully developing better treatments for chronic conditions?
September 29, 2026
Tiny Health Raised $33 Million in Series B FundingThe Austin-based biotech startup secured capital to expand its microbiome research and B2B health platform.
September 22, 2026
AlphaRose Therapeutics Secured SBIR Fast Track GrantThe Austin-based biotech firm received federal funding to advance its drug candidate for a rare genetic condition.
